作者
Inke R König, Oliver Fuchs, Gesine Hansen, Erika von Mutius, Matthias V Kopp
发表日期
2017/10/1
来源
European respiratory journal
卷号
50
期号
4
出版商
European Respiratory Society
简介
The term “precision medicine” has become very popular over recent years, fuelled by scientific as well as political perspectives. Despite its popularity, its exact meaning, and how it is different from other popular terms such as “stratified medicine”, “targeted therapy” or “deep phenotyping” remains unclear. Commonly applied definitions focus on the stratification of patients, sometimes referred to as a novel taxonomy, and this is derived using large-scale data including clinical, lifestyle, genetic and further biomarker information, thus going beyond the classical “signs-and-symptoms” approach.
While these aspects are relevant, this description leaves open a number of questions. For example, when does precision medicine begin? In which way does the stratification of patients translate into better healthcare? And can precision medicine be viewed as the end-point of a novel stratification of patients, as implied, or is it …
学术搜索中的文章
IR König, O Fuchs, G Hansen, E von Mutius, MV Kopp - European respiratory journal, 2017